Drug survival and reasons for discontinuation of the first biological disease modifying antirheumatic drugs in Thai patients with rheumatoid arthritis: Analysis from the Thai Rheumatic Disease Prior Authorization registry.

Pongthorn NarongroeknawinParawee ChevaisrakulNuntana KasitanonTasanee KitumnuaypongAjanee MahakkanukrauhBoonjing SiripaitoonWanruchada Katchamartnull null

Published in: International journal of rheumatic diseases (2016)

Over 5 years, only one-third of patients continued using their first bDMARD. The leading cause of drug discontinuation was inadequate response.

Keyphrases

rheumatoid arthritis
end stage renal disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
emergency department
disease activity